What is the FDAs role in approving Ozempic
Sun Pharmaceutical Industries has received approval from the South African Health Products Regulatory Authority (SAHPRA) to manufacture and market a generic version of semaglutide injection in South Africa for the treatment of adults with inadequately controlled type 2 diabetes
The patient has already demonstrated that they respond to the medication at this total dose, and the modification addresses tolerability without changing efficacy expectations
The pill achieved an average weight loss of 13.6% over 64 weeks in OASIS 4, 1 while injectable Wegovy 2.4 mg achieved 14.9% over 68 weeks in STEP 1
Of course, the federal lawsuit alleges that even in its purest form, Ozempic can be dangerous, and the manufacturer is now properly warning of the risks associated with the drug
This blood pressure reduction is clinically meaningful even modest decreases in systolic BP are associated with lower cardiovascular risk